The Pharmaceutical Journal
Vol 274 No 7347 p509
30 April 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Related websites
HRT links

HRT increases womb cancer

Postmenopausal women taking oestrogen-only hormone replacement therapy or tibolone have a greater risk of endometrial cancer than those taking combination HRT, say researchers. However, they note that since the risk of breast cancer is greater with combination HRT, total cancer incidence remains higher for combined HRT (Lancet 2005;365:1543).